Patents-Review.com
ClassID:

96733 ⎘

C07K7/00 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Sub-classes:
Recent Application in this class:
#1
20260124229
2026-05-07

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #2
20260124228
2026-05-07

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #3
20260116918
2026-04-30

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

 #4
20260115219
2026-04-30

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #5
20250388933
2025-12-25

METHODS AND STRAIN

 #6
20250381211
2025-12-18

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #7
20250353902
2025-11-20

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

 #8
20250289852
2025-09-18

ANTIFUNGAL AGENTS AND USES THEREOF

 #9
20250236663
2025-07-24

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

 #10
20250235519
2025-07-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS

 #11
20250223335
2025-07-10

PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS

 #12
20250145686
2025-05-08

UTERINE CANCER TREATMENTS

 #13
20250145684
2025-05-08

IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS

 #14
20250144192
2025-05-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS

 #15
20250034545
2025-01-30

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

 #16
20240408166
2024-12-12

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #17
20240248090
2024-07-25

THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO

 #18
20240228537
2024-07-11

BLOCK COPOLYPEPTIDES AND USE THEREOF

 #19
20240192215
2024-06-13

THIOREDOXIN 1 EPITOPE AND MONOCLONAL ANTIBODY SPECIFICALLY BINDING THERETO

 #20
20240166751
2024-05-23

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

 #21
20240148856
2024-05-09

RESPIRATORY SYNCYTIAL VIRUS VACCINE

 #22
20240124523
2024-04-18

OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY

 #23
20240122959
2024-04-18

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #24
20240082382
2024-03-14

HUMAN PAPILLOMAVIRUS TYPE 31 CHIMERIC PROTEIN AND USE THEREOF

 #25
20240075117
2024-03-07

MICROBIOTA SEQUENCE VARIANTS OF TUMOR-RELATED ANTIGENIC EPITOPES

 #26
20240066112
2024-02-29

NOROVIRUS VIRUS-LIKE PARTICLE, IMMUNE COMPOSITION, OR KIT, AND USE THEREOF

 #27
20230355541
2023-11-09

Enzymatically cleavable self-assembled nanoparticles for morphogen delivery

 #28
20230332183
2023-10-19

Methods and strain

 #29
20230201241
2023-06-29

Compositions comprising circular polyribonucleotides and uses thereof

 #30
20230174959
2023-06-08

PLANT GENOME EDITING TECHNIQUE NOT RELYING ON GENE RECOMBINATION UTILIZING CELL MEMBRANE-PERMEABLE PEPTIDE

 #31
20230094790
2023-03-30

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #32
20230070937
2023-03-09

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #33
20230065320
2023-03-02

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #34
20230051035
2023-02-16

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #35
20230040528
2023-02-09

METHODS TO SPECIFICALLY PROFILE PROTEASE ACTIVITY AT LYMPH NODES

 #36
20230031307
2023-02-02

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

 #37
20220401557
2022-12-22

MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITION, METHOD FOR IDENTIFYING LINEAR EPITOPE, AND METHOD FOR PREPARING MULTIPLE ANTIGEN BINDING MOLECULAR FUSION

 #38
20220372122
2022-11-24

Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof

 #39
20220354939
2022-11-10

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

 #40
20220348609
2022-11-03

COMPUTATIONAL DESIGN OF ALPHA(V) BETA (6) INTEGRIN BINDING PROTEINS

 #41
20220339272
2022-10-27

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

 #42
20220323502
2022-10-13

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #43
20220323501
2022-10-13

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #44
20220282239
2022-09-08

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

 #45
20220265757
2022-08-25

Hemostatic composition and hemostatic method using hemostatic composition

 #46
20220257739
2022-08-18

Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells

 #47
20220186285
2022-06-16

METHODS AND COMPOSITIONS FOR NONINVASIVE DETECTION OF ORGAN TRANSPLANT REJECTION

 #48
20220162263
2022-05-26

ANTIFUNGAL AGENTS AND USES THEREOF

 #49
20220155296
2022-05-19

Peptides, Reagents And Methods For Detecting Food Allergy

 #50
20220118071
2022-04-21

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #51
20220105148
2022-04-07

Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation

 #52
20220054613
2022-02-24

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #53
20220031824
2022-02-03

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #54
20220023404
2022-01-27

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #55
20220023403
2022-01-27

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #56
20220023331
2022-01-27

Compositions comprising circular polyribonucleotides and uses thereof

 #57
20220016227
2022-01-20

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #58
20220008472
2022-01-13

Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methods

 #59
20210401888
2021-12-30

Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers

 #60
20210363186
2021-11-25

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostic and therapeutic delivery

 #61
20210324044
2021-10-21

Heterologous targeting peptide grafted AAVs

 #62
20210322527
2021-10-21

Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers

 #63
20210309715
2021-10-07

Uterine cancer treatments

 #64
20210300968
2021-09-30

Uterine cancer treatments

 #65
20210290743
2021-09-23

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

 #66
20210275565
2021-09-09

Compositions comprising circular polyribonucleotides and uses thereof

 #67
20210268089
2021-09-02

Peptides and combination of peptides for use in immunotherapy against Hepatocellular carcinoma (HCC) and other cancers

 #68
20210261614
2021-08-26

Immunotherapy against several tumors including neuronal and brain tumors

 #69
20210238227
2021-08-05

Immunotherapy against several tumors including neuronal and brain tumors

 #70
20210198343
2021-07-01

Peptidic TGF-beta antagonists

 #71
20210181188
2021-06-17

MHC-II GENOTYPE RESTRICTS THE ONCOGENIC MUTATIONAL LANDSCAPE

 #72
20210161938
2021-06-03

Compositions comprising circular polyribonucleotides and uses thereof

 #73
20210107967
2021-04-15

Precision activation of HIV-specific CTLS to eliminate reactivated latent T cells

 #74
20210101934
2021-04-08

Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain

 #75
20210087229
2021-03-25

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic

 #76
20210060116
2021-03-04

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

 #77
20200405831
2020-12-31

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #78
20200376103
2020-12-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #79
20200370032
2020-11-26

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

 #80
20200362017
2020-11-19

Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases

 #81
20200360295
2020-11-19

Enzymatically cleavable self-assembled nanoparticles for morphogen delivery

 #82
20200309778
2020-10-01

Thioredoxin 1 epitope, encoding nucleic acid and methods of binding a monoclonal antibody

 #83
20200306286
2020-10-01

COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF

 #84
20200254055
2020-08-13

Pharmaceutical compositions and preparations for administration to the eye

 #85
20200239522
2020-07-30

Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery

 #86
20200222519
2020-07-16

Universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (MSI) cancers

 #87
20200087686
2020-03-19

METHODS AND STRAIN

 #88
20200046799
2020-02-13

Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation

 #89
20200025774
2020-01-23

Microbiota sequence variants of tumor-related antigenic epitopes

 #90
20190389934
2019-12-26

Heterologous targeting peptide grafted AAVS

 #91
20190359694
2019-11-28

Serological assay for the detection of zika virus-specific antibodies utilizing overlapping peptides comprising an NS2B epitope

 #92
20190343916
2019-11-14

Peptides useable for treatment of disorders of the eye

 #93
20190314447
2019-10-17

Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides

 #94
20190309019
2019-10-10

Polypeptide and use thereof

 #95
20190307785
2019-10-10

Compositions comprising circular polyribonucleotides and uses thereof

 #96
20190300599
2019-10-03

Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof

 #97
20190292218
2019-09-26

Thiol-yne based peptide stapling and uses thereof

 #98
20190225707
2019-07-25

Methods for the treatment of a cancer or fibrotic disorder associated with MENA or MENA(INV) by administering a map kinase inhibitor

 #99
20190202863
2019-07-04

Cyclic peptides and uses thereof

 #100
20190128873
2019-05-02

Methods to specifically profile protease activity at lymph nodes

 #101
20190112350
2019-04-18

Peptidic TGF-beta antagonists

 #102
20190112338
2019-04-18

Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban

 #103
20190094236
2019-03-28

Method for diagnosing amyotrophic lateral sclerosis using signal peptide as indicator

 #104
20190062370
2019-02-28

Method of purifying antifungal compounds and exopolysaccharides from a microbial cell culture

 #105
20190046636
2019-02-14

Amino acid and peptide conjugates and conjugation process

 #106
20190023739
2019-01-24

Peptide for cancer treatment and pharmaceutical composition containing same

 #107
20190017040
2019-01-17

Compounds and methods for stabilizing thrombin activity

 #108
20190016822
2019-01-17

Self-crosslinking antibodies

 #109
20190000947
2019-01-03

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #110
20180371448
2018-12-27

MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY

 #111
20180360904
2018-12-20

Hemostatic composition and hemostatic method using hemostatic composition

 #112
20180344814
2018-12-06

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

 #113
20180327448
2018-11-15

Purification method, purification kit, and silicon oxide-binding tag for use therein

 #114
20180319848
2018-11-08

Modifications of cupredoxin derived peptides

 #115
20180319842
2018-11-08

Compounds and methods for treating pain

 #116
20180318357
2018-11-08

Pharmaceutical composition for treating diabetes, comprising pancreatic islet cells and elastin-like artificial extracellular matrix

 #117
20180273584
2018-09-27

HER2 peptide regents and methods

 #118
20180265571
2018-09-20

Heterologous targeting peptide grafted AAVS

 #119
20180265559
2018-09-20

Polypeptides, nucleic acids and uses thereof

 #120
20180207253
2018-07-26

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #121
20180207252
2018-07-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS

 #122
20180193410
2018-07-12

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

 #123
20180148508
2018-05-31

Masking chimeric antigen receptor T cells for tumor-specific activation

 #124
20180125972
2018-05-10

Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion

 #125
20180072772
2018-03-15

Mutant Akt-specific capture agents, compositions, and methods of using and making

 #126
20170304456
2017-10-26

FAST DISSOLVING PHARMACEUTICAL COMPOSITION

 #127
20170296695
2017-10-19

Peptide having zirconia-binding capacity

 #128
20170283475
2017-10-05

Cancer vaccine compositions and methods of use thereof

 #129
20170219607
2017-08-03

Method for identifying epitope on protein

 #130
20170218019
2017-08-03

Peptide for inducing multinucleation in cells, and use therefor

 #131
20160324917
2016-11-10

Compositions and methods for preventing and reducing inflammation and treating disorders associated with inflammation

 #132
20160311880
2016-10-27

Polypeptides, nucleic acids and uses thereof

 #133
20160272698
2016-09-22

Regulating Bacillus anthracis lethal factor activity via an activating epitope region

 #134
20160250317
2016-09-01

Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof

 #135
20160250307
2016-09-01

Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers

 #136
20160208237
2016-07-21

Modifications of peptide compositions to increase stability and delivery efficiency

 #137
20160096872
2016-04-07

Methods for producing peptides using engineered inteins

 #138
20160075740
2016-03-17

Antifungal agents and uses thereof

 #139
20160022763
2016-01-28

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

 #140
20150361138
2015-12-17

KISS1R receptor agonist compounds and use thereof for inducing ovulation in mammals

 #141
20150328283
2015-11-19

NOVEL ANTIMICROBIAL AGENTS

 #142
20150283078
2015-10-08

Liposomes for in-vivo delivery

 #143
20150239940
2015-08-27

Compositions and methods for measles virus inhibition

 #144
20150218211
2015-08-06

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

 #145
20150166603
2015-06-18

Decoy peptides inhibiting protein phosphatase 1-mediated dephosphorylation of phospholamban

 #146
20150159194
2015-06-11

Real-time assay for the detection of botulinum toxin

 #147
20150153365
2015-06-04

Polypeptides, nucleic acids and uses thereof

 #148
20150118213
2015-04-30

Compounds and methods for stabilizing thrombin activity

 #149
20150045300
2015-02-12

Fast dissolving pharmaceutical composition

 #150
20150044246
2015-02-12

Method for identifying immunoreactive peptides

 #151
20150024997
2015-01-22

Antifungal agents and uses thereof

 #152
20150024490
2015-01-22

Chemically labile peptide-presenting surfaces for cellular self-assembly

 #153
20140371143
2014-12-18

Peptide inhibiting rankl-rank interaction and the use thereof

 #154
20140357572
2014-12-04

Neurotrophic peptides for the treatment of tauopathies

 #155
20140336105
2014-11-13

Anti-inflammatory peptides and use thereof

 #156
20140315787
2014-10-23

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

 #157
20140271693
2014-09-18

Aqueous liquid composition

 #158
20140206840
2014-07-24

Fluorescent labeling of living cells

 #159
20140154812
2014-06-05

Real-time assay for the detection of botulinum toxin

 #160
20140093473
2014-04-03

Amphiphilic linear peptidepeptoid and hydrogel comprising the same

 #161
20140086953
2014-03-27

Attenuated Chikungunya virus

 #162
20140072650
2014-03-13

GELATIN EXTRACT MADE FROM SKATE RAY SKIN AND ANTIHYPERTENSIVE COMPOSITION HAVING PEPTIDE ISOLATED FROM EXTRACT AS ACTIVE INGREDIENT

 #163
20140045743
2014-02-13

Compositions and methods for coronavirus inhibition

 #164
20140024606
2014-01-23

Peptidomimetics comprising N-amino cyclic urea residues and uses thereof

 #165
20130323254
2013-12-05

Therapeutic anti-TIRC7 antibodies for use in immune related and other diseases

 #166
20130316942
2013-11-28

Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof

 #167
20130281662
2013-10-24

Process for the manufacture of Degarelix and its intermediates

 #168
20130243802
2013-09-19

Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy

 #169
20130224231
2013-08-29

Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity

 #170
20130165626
2013-06-27

ANTIFREEZE PROTEIN

 #171
20130133102
2013-05-23

TARGETING SIGNAL FOR INTEGRATING PROTEINS, PEPTIDES AND BIOLOGICAL MOLECULES INTO BACTERIAL MICROCOMPARTMENTS

 #172
20130029903
2013-01-31

Azuvirin peptides

 #173
20130018004
2013-01-17

Protein peptide hydrogels

 #174
20120289458
2012-11-15

Treatment of influenza virus infection

 #175
20120178138
2012-07-12

Modifications of peptide compositions to increase stability and delivery efficiency

 #176
20120122788
2012-05-17

ε-Polylysine conjugates and the use thereof

 #177
20120100086
2012-04-26

Proteasome-activating lightening peptidic hydrolyzates and compositions containing them

 #178
20120070897
2012-03-22

Method for enucleating nucleated erythrocyte, and enucleation inducer

 #179
20120028350
2012-02-02

Bone marrow targeting peptides

 #180
20120021947
2012-01-26

System and Method to Obtain Oligo-Peptides with Specific High Affinity to Query Proteins

 #181
20110218157
2011-09-08

Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome

 #182
20110217325
2011-09-08

T cell epitopes of the Cyn d 1 allergen from bermuda grass pollen

 #183
20110197711
2011-08-18

Peptide mediated synthesis of metallic and magnetic materials

 #184
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

 #185
20110178010
2011-07-21

Use of peptides for promoting wound healing

 #186
20110152200
2011-06-23

Methods and compositions for inhibition of BCL6 repression

 #187
20110136726
2011-06-09

NOVEL ANTIMICROBIAL AGENTS

 #188
20110020270
2011-01-27

Compositions comprising E-selectin antagonists and uses therefor

 #189
20110002881
2011-01-06

Treatment of immunocompromised conditions

 #190
20100267608
2010-10-21

Modifications of cupredoxin derived peptides and methods of use thereof

 #191
20100255194
2010-10-07

Gradient fabrication to direct transport on a surface

 #192
20100222261
2010-09-02

Peptidic antagonists of class III semaphorins/neuropilins complexes

 #193
20100135953
2010-06-03

Method of treatment of age-related macular degeneration

 #194
20100099614
2010-04-22

Antimicrobial Peptides and Methods of Use

 #195
20100047226
2010-02-25

Compositions and methods for inhibiting tumor cell growth

 #196
20090264362
2009-10-22

Influenza virus inhibiting peptides

 #197
20090246217
2009-10-01

Peptides for modulating innate immunity

 #198
20090042769
2009-02-12

Modifications of peptide compositions to increase stability and delivery efficiency

 #199
20080287654
2008-11-20

PEPTIDE MEDIATED SYNTHESIS OF METALLIC AND MAGNETIC MATERIALS

 #200
20070299244
2007-12-27

Liposome allowing liposome-entrapped substance to escape from endosome

 #201
20070287174
2007-12-13

Peptide mediated synthesis of metallic and magnetic materials

 #202
20070032428
2007-02-08

Antimicrobial agents

 #203
20070020614
2007-01-25

Development of novel anti-microbial agents based on bacteriophage genomics

 #204
20060280754
2006-12-14

Influenza virus inhibiting peptides

 #205
20060165684
2006-07-27

Therapeutic anti-tirc7 antibodies for use in immune related and other diseases

 #206
20060062921
2006-03-23

Gradient fabrication to direct transport on a surface

 #207
20050221350
2005-10-06

Method for identifying immunoreactive peptides

 #208
20050075481
2005-04-07

T cell epitopes of the cyn d 1 allergen from bermuda grass pollen

 #209
20050064508
2005-03-24

Peptide mediated synthesis of metallic and magnetic materials